Questions: Are either severe other joint disease or obesity associated with a slower rate of recovery after total hip or knee replacement surgery? Are they associated with less absolute recovery up to one year post-surgery? Design: Prospective, longitudinal, observational study over 12 months. Participants: Ninety-nine patients (knee = 55, hip = 44) stratified according to the presence of severe other joint disease and obesity. Outcome measures: Pain in operated joint, and 15-m Walk Test and Timed Up and Go Test measured pre-and at 2, 6, 12, 26, and 52 weeks post-surgery. Walking aid utilisation and global improvement were measured at 52 weeks. Results: For rate of recovery, the participants with severe other joint disease recovered more slowly than the non-severe group in terms of mobility (15-m Walk Test p = 0.005). For absolute recovery, participants with severe other joint disease walked 0.27 m/s (95% CI 0.15 to 0.40) more slowly on the 15-m Walk Test, took 4.0 s (95% CI 2.3 to 5.8) longer on the Timed Up and Go Test, and had 6.8 times greater chance (95% CI 2.8 to 16.5) of using a walking aid than the non-severe group at 52 weeks. This profile was similar for the obese group compared with the non-obese group. At 52 weeks, the majority (95%) of participants reported significant (better/much better) global improvement. Conclusion: Severe other joint disease and obesity are associated with poorer recovery after surgery. Clinician and patient expectations, rehabilitation, and benchmarking can be guided by these findings. 
Introduction
Recovery after total knee or hip replacement surgery is influenced by intrinsic patient factors including preoperative mental health , general health status (Long et al 2005) , age (Nilsdotter et al 2003 , Roder et al 2003 , gender (Roder et al 2003) and the number of medical co-morbidities (Fortin et al 2002 . Self-reported pre-operative pain and function predict pain and function 6 to 42 months post-surgery (Fortin et al 2002 , Fortin et al 1999 , Nilsdotter et al 2003 ; and age and gender affect self-reported ambulatory capacity up to 15 years post-hip replacement (Roder et al 2003) . In terms of measured physical performance, preoperative knee stiffness is a strong predictor of stiffness up to three years post-knee replacement (Gandhi et al 2006 , Ritter et al 2003 , and pre-operative quadriceps strength predicts improvement in Timed Up and Go and stair climbing one year post-knee replacment (Mizner et al 2005) . Socioeconomic factors also predict recovery, with low-level educational attainment associated with poorer recovery of function (Bischoff-Ferrari et al 2004 , Fortin et al 2002 .
Other factors observed to influence recovery include the presence of severe other joint disease and obesity. Multijoint dysfunction is common amongst joint replacement recipients (Hawker et al 1998 , Roder et al 2003 , and the 10-year risk of progression to a contralateral knee replacement following unilateral knee replacement is high (37-63% according to McMahon and Block 2003) ; thus, it is not surprising that other joint disease (notably, lumbar or lower limb) can impede recovery. Patients with other joint disease or comorbidity that impairs mobility, report lower ambulatory capacity and function following hip replacement than those who do not (Roder et al 2003) . Similarly, other joint disease predicts self-reported function following primary knee (Hawker et al 1998) and hip replacement (Bischoff-Ferrari et al 2004 , Nilsdotter et al 2003 . In fact, the aforementioned finding that pre-operative function predicts post-operative function, may be explained partly by the presence of other joint disease and not just the pre-operative dysfunction of the operated joint.
The effect of obesity on recovery is less straightforward. Similar relative improvements in self-reported pain and function in obese and non-obese patients have been observed (Spicer et al 2001 , Stickles et al 2001 . Others have demonstrated that self-reported function is poorer in obese patients post-hip (Bischoff-Ferrari et al 2004 , Moran et al 2005 , Roder et al 2003 and post-knee replacement (Foran et al 2004 , Hawker et al 1998 , and poorer in obese women after hip replacement compared to obese men (Lubbeke et al 2007) . Similarly, the impact of body mass on prosthesis longevity is also unclear. Some investigators report worse prosthesis durability in hip replacement patients with body mass greater than 80 kg (Surin and Sundholm 1983) and in morbidly-obese knee replacement patients (Foran et al 2004) , whilst others have observed no differences in relation to obesity (Hawker et al 1998 , Spicer et al 2001 .
This study prospectively evaluates the multidimensional effect of severe other joint disease and obesity on outcomes following joint replacement surgery. Such information is useful for informing patients about realistic expectations from surgery and in guiding clinicians in their development of appropriate rehabilitation goals, strategies and benchmarking. The research questions were:
Are either severe other joint disease or obesity 1.
associated with a slower rate of recovery after total hip or knee replacement surgery?
Are they associated with less absolute recovery up to 2.
one year post-surgery?
Method Design
A prospective, observational study was undertaken in a joint replacement centre within a metropolitan hospital. Measurements were conducted one to two weeks presurgery at a pre-admission clinic. Subsequent measurements were conducted at 2, 6, 12, 26 and 52 weeks post-surgery. Assessor-blinding to the presence of obesity or severe other joint disease was not possible. Assessments were performed by the same two observers, however, who were trained in the conduct of each test and who followed a standardised pro forma. Interpreters were used when required. Ethical approval for the study was provided by the Sydney South West Area Health Service Human Ethics Committee. Patients provided written informed consent.
Participants
Consecutive patients undergoing primary unilateral knee or hip replacement surgery across 2003 and 2004 were approached. Exclusion criteria included: surgical procedures additional to the planned replacement; a second replacement planned within one year of the first; dementia; and residing more than 50 km from the hospital. Demographic and surgical variables -and later, post-operative complications -were obtained via interview and chart review.
Outcome measuress
Pain in the operated joint was measured using a 10-cm visual analogue scale. Mobility was measured using the 15-m Walk Test, the Timed Up and Go Test (Mizner et al 2005) , and walking aid utilisation at one year. Global improvement in the operated joint was measured using a 5-level scale: much better; better; same; worse; and much worse. Both tools have face, content, and construct validity, demonstrate good reliability, and are responsive to small changes in small samples (Bellamy et al 1988 , Ware 2000 
Data analysis
A sample of 125 patients, allowing for a 20% loss to followup, provided an 80% chance of detecting a small main effect (time) (0.28 SD) and a moderate between-group effect (0.57 SD) in any variable. The cohort was stratified according to the presence of severe other joint disease both pre-operatively and at one year post-surgery using an adapted version of the Charnley Classification for co-morbidity (Charnley 1972) . Patients reporting that their mobility was not held back by severe other joint disease were classified as Charnley Class A and denoted as the Non-Severe Group. Patients reporting their mobility was impeded by severe other joint disease were classified as Charnley Class B (contralateral joint) or C (remote joint), and collectively denoted as the Severe Group. Patients were also stratified according to body mass index (BMI): obese = BMI ≥ 30; non-obese = BMI < 30.
Between-group differences in demographic and surgical profiles were analysed using independent t-tests or the χ 2 Test of Independence. Between-group differences in recovery rates were analysed for continuous variables (pain ,   Table 1 . Demographic, surgical, discharge, and major complication characteristics of the participants. Female gender, n (%) 27 (64) 29 (51) 32 (64) 24 (49) Osteoarthritis, n (%) 34 (81) 49 (86) 42 (84) 41 (84) Total knee replacement, n (%) 20 (48) 35 (61) 32 (64) 23 (47) Co-morbidities, n (%) 3 or more significant conditions Cardiac disease Respiratory disease Peripheral vascular disease Types 1 or 2 diabetes Hypertension 18 (43) 8 (19) 12 (29) 6 (14) 13 (31) 29 (69) 14 (25) 15 (26) 11 (19) 6 (11) 10 (18) 32 (56) 2 (40) 12 (24) 15 (30) 4 (8) 17 (34) 35 (70) 12 (24) 11 (22) 8 (16) 8 (16) 6 (12) 26 (53 mobility, WOMAC and SF-36) using repeated measures planned orthogonal contrasts. Mean differences (95% CI) at 52 weeks were used to determine differences in absolute recovery in the continuous variables. Odds ratios (95% CI) at one year were used to determine differences for the chance of walking aid use and global improvement. For all analyses, p < 0.05 was deemed significant.
Results
Flow of participants through the study Figure 1 details flow of participants through the study. Of the 122 patients who consented to follow-up, 99 (81%) were available for follow-up at one year (Table 1) . Of these 99, 57 (58%) had no severe other joint disease (Non-severe Group), and 42 (42%) had severe other joint disease (Severe Group), 25 of whom were waitlisted for replacement surgery of another joint at one year. Of the 99, 50 (51%) were obese, 55 (56%) (including 32 females) had a total knee replacement, had an average age of 70 years (SD 8), and an average BMI of 32 (SD 6); 44 (44%) (including 24 females) had a total hip replacement, were aged 65 years old (SD 9), and had a BMI of 30 (SD 5). Table 1 summarises the demographic, surgical, discharge, and complication characteristics of the participants. Characteristics were essentially similar across groups, however, participants with severe other joint disease had a significantly (p = 0.01) higher body mass index then those without severe other joint disease. Also, participants who were obese had a significantly (p < 0.01) higher body mass index then those who were not obese, and a higher incidence of diabetes (p < 0.01). Cement fixation, patella resurfacing and prosthesis type were clinician-dependent (n = 6 surgeons), as was the type of anaesthesia (n = 4 anaesthetists). No patients died, had revision surgery, or underwent manipulation under anaesthetic in the first post-operative year. Patients received daily physiotherapy until discharge, and prophylaxis for thromboembolism and infection. Referral to ongoing physiotherapy was routine practice, with 90% of patients attending outpatient programs.
Effect of severe other joint disease
Severe and non-severe group data and between-group differences at every measurement occasion are presented in Table 2, while Table 3 Timed mobility improved after the first 2 post-operative weeks. In terms of rate of recovery, the severe group recovered more slowly than the non-severe group in the 15-m Walk Test (p = 0.005). Rate of recovery was similar between the groups in pain and mobility (Timed Up and Go Test). Of the English-speaking subgroup, the severe group recovered more slowly than the non-severe group in 2 of the 3 domains of the WOMAC (stiffness p = 0.03 and function p = 0.02) and 2 of the 8 domains of the SF-36 (physical function p = 0.01, and general health p = 0.01).
Detailed statistical results are presented in Tables 3 and 4  (see eAddenda for Tables 3 and 4 ).
In terms of absolute recovery at 52 weeks, the severe group walked 0.27 m/s (95% CI 0.15 to 0.40) more slowly on the 15-m Walk Test and took 4.0 s (95% CI 2.3 to 5.8) longer on the Timed Up and Go Test than the non-severe group. There was a 6.8 greater chance (95% CI 2.8 to 16.5) that the severe group would be using a walking aid since 27 (64%) of them did compared with 12 (21%) of the non-severe group. On the other hand, pain was no worse (mean difference 0.1 cm, 95% CI -1.0 to 0.8) and global improvement was similar (OR 0.7, 95% CI 0.1 to 5.4) in the severe group compared with the non-severe group. Of the English-speaking subgroup, the severe group scored worse on the function domain of the WOMAC (mean difference 12.2 out of 68, 95% CI 3.5 to 20.9) and the physical function (mean difference 23%, 95% CI 10 to 37), role physical (mean difference 26%, 95% CI 11 to 42), bodily pain (mean difference 20%, 95% CI 4 to 36), vitality (mean difference 14%, 95% CI 1 to 27), and social function (mean difference 16%, 95% CI 1 to 31) domains of the SF-36 compared with the non-severe group.
Effect of obesity
Obese and non-obese group data and between-group differences at every measurement occasion are presented in Table 6 , while Timed mobility improved after the first 2 post-operative weeks. In terms of rate of recovery, the obese and nonobese groups were similar in mobility (15-m Walk Test and Timed Up and Go Test), and pain, except after 26 weeks where the obese group continued to report improvement in pain while the non-obese group did not (p = 0.003).
Of the English-speaking subgroup, the rate of recovery was similar between the groups for WOMAC and SF-36. Detailed statistical results are presented in Tables 4 and 5  (see eAddenda for Tables 4 and 5 ).
In terms of absolute recovery at 52 weeks, the obese group walked 0.23 m/s (95% CI 0.10 to 0.36) more slowly on the 15-m Walk Test and took 3.1 s (95% CI 1.3 to 4.9) longer on the Timed Up and Go Test than the non-obese group. There was a 2.8 greater chance (95% CI 1.2 to 6.4) that the obese group would be using a walking aid since 25 (50%) of them did compared with 13 (27%) of the non-obese group. On the other hand, pain was no worse (mean difference 0.5 cm, 95% CI 0.4 to 1.4) and global improvement was similar (OR 0.33, 95% CI 0.03 to 3.25) in the obese group compared with the non-obese group. Of the English-speaking subgroup, the obese group scored worse on the pain (mean difference 2.5 out of 20, 95% CI 0.2 to 4.9) and the function (mean difference 9.6 out of 68, 95% CI 1.0 to 18.2) domains of the WOMAC, and the physical function (mean difference 18%, 95% CI 5 to 32), bodily pain (mean difference 17%, 95% CI 1 to 33), and the social function (mean difference 17%, 95% CI 3 to 32) domains of the SF-36 compared with the non-obese group. (22) 34 (20) 58 (20) 37 (24) 60 (24) -5.7 (-18 to 6) -24 (-35 to -12) -23 (-37 to -10) Role physical 26 (22) 34 (25) 37 (23) 59 (27) 42 (29) 68 (26 (17) 55 (23) 58 (26) 65 (20) 59 (23) 66 ( Table 6 . Mean (SD) of obese (n = 50) and non-obese (n = 49) groups and mean (95% CI) difference between groups for outcomes measured on every occasion. 
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Discussion
Primary unilateral total knee or hip replacement conferred significant improvements in many outcomes. The improvements in the SF-36 domains were such that the scores approached population norms (ABS 1995) (more so for nonobese patients and those without severe other joint disease), and this observation accords with other local (Bachmeier et al 2001 , March et al 1999 and international studies (Fortin et al 1999 , Fortin et al 2002 , Stickles et al 2001 reporting outcomes one to two years post joint replacement. The large improvements observed in WOMAC scores are also typical (Bachmeier et al 2001 , Kennedy et al 2006 , Stickles et al 2001 , as are the improvements in operated joint pain (Roder et al 2003) , and the finding that, for many outcomes, most improvements occurred within the first six months post-surgery. The stratification of patients according to the presence of severe other joint disease or obesity was useful as it revealed that the presence of these impairments was associated with poorer rates of recovery and/or absolute recovery for several outcomes at one year.
Poorer WOMAC scores up to seven years post-surgery in patients with severe other joint disease have been reported (Bischoff-Ferrari et al 2004 , Hawker et al 1998 , Nilsdotter et al 2003 , Stickles et al 2001 . Here, WOMAC function scores were worse overall in such patients; close inspection of the data indicating this was mainly explained by differences after surgery. Why index (operated) joint function was worse post-operatively in patients with severe other joint disease is intriguing and may have several explanations. The presence of other joint disease may compromise recovery of function in the operated joint, and thus may explain post-operative joint-specific differences in function. Additionally, patients with severe multijoint dysfunction may have greater index joint dysfunction pre-operatively, although this explanation is not supported by the current data since mean differences at baseline in WOMAC scores were not significantly different (Table 3 ). Alternatively, it is possible when interpreting the WOMAC, and despite instruction to do so, that patients may be unable to totally isolate the effects of the operated joint from the debilitating effects of other dysfunctional joints.
The differential improvements observed here in many of the SF-36 domains based on the presence of severe other joint disease -and the poorer scores overall in some domains -were anticipated given that the SF-36 encompasses other joints and total bodily pain. Obesity was also associated with poorer scores in several domains, concurring with the findings of Stickles et al (2001) . Other investigators have also observed poorer function in obese patients using the Harris Hip Score (Moran et al 2005) , Knee Society Score (Spicer et al 2001) , and WOMAC (Hawker et al 1998 , Stickles et al 2001 , but all conclude that obese patients are able to gain considerable improvements from surgery, and so joint replacement remains an appropriate treatment option. This conclusion is corroborated by the current study since, independent of obesity, patients perceived major global improvements in their joint behaviour.
Though obesity or severe other joint disease did not preclude improvement in walk speed, stratification of the cohort revealed that patients with such co-morbidities remained slower than age-matched norms (1.33-1.59 m/s); 8 sec for Timed Up and Go Test) (Steffen et al 2002) . The slower mobility associated with severe other joint disease and/or obesity is clinically relevant as reliance on walking aids was greater, and function (assessed by WOMAC and SF-36) appeared more compromised in these patients.
Stratification versus multiple regression analyses
It was not possible in the one study to also address the effect on outcomes of extrinsic influences such as surgeon volume, the annual volume of surgery performed by a facility, prosthesis factors, and a multitude of clinical practices extending from the pre-operative period to the downstream post-discharge period. Whilst it is not yet possible to assemble all the factors into a hierarchy of importance, the current study is important as it uniquely quantifies the impact of time, severe other joint disease, and obesity on a range of clinical and patient-centred outcomes.
A primary focus here was examination of the influence of specific co-morbidities on recovery at various time points. Stratification of the cohort by co-morbidity and the use of repeated measures analyses provided a robust and clinically useful way to do this. Multiple regression analysis may be viewed as a stronger approach for identifying important predictor variables owing to its simultaneous consideration of confounding factors, but for examining recovery across various time points, it is not the preferred approach. For completeness, however, results from post-hoc multiple regression analyses that identified predictors of outcomes at one year are provided in Appendix 1 (see eAddenda for Appendix 1). The regressions (that also included age, gender, surgery type and number of co-morbidities as predictor variables) were consistent with the results from the contrast analyses. That is, the presence of severe other joint disease in particular appears to be a most important predictive factor for several outcomes.
Implications for rehabilitation
That obese patients or those with severe other joint disease still experience some degree of dependence in function one year post-surgery has implications for rehabilitation. Rehabilitation offered to patients presenting within this time period should accommodate differences in physical and function based on the co-morbidities described. Intuitively, hydrotherapy may be more appropriate for some in view of its capacity to unload immersed joints; and since obesity is potentially modifiable it is recommended that such patients be referred for weight management. Finally, rehabilitation programs in Australia following knee replacement cease six to eight weeks after surgery (Naylor et al 2006) . This would appear to be before recovery in many domains has stabilised, and thus the available rehabilitation programs may be of insufficient duration. 
